Gilat Satellite Networks Ltd.
|
|
(Registrant)
|
|
Dated August 10, 2010
|
By: /s/ Rachel Prishkolnik
|
Rachel Prishkolnik
|
|
Corporate Secretary
|
GILAT SATELLITE NETWORKS LTD.
|
CONDENSED CONSOLIDATED BALANCE SHEET
|
US dollars in thousands
|
June 30,
|
December 31,
|
|||||||
2010
|
2009
|
|||||||
Unaudited
|
||||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
127,309 | 122,672 | ||||||
Short-term bank deposits
|
22,593 | 31,729 | ||||||
Available-for-sale marketable securities
|
4,674 | - | ||||||
Short-term restricted cash
|
1,377 | 1,782 | ||||||
Restricted cash held by trustees
|
6,669 | 2,137 | ||||||
Trade receivables, net
|
43,925 | 45,597 | ||||||
Inventories
|
13,721 | 13,711 | ||||||
Other current assets
|
21,389 | 19,068 | ||||||
Total current assets
|
241,657 | 236,696 | ||||||
LONG-TERM INVESTMENTS AND RECEIVABLES:
|
||||||||
Long-term restricted cash
|
4,392 | 4,896 | ||||||
Severance pay fund
|
9,435 | 9,912 | ||||||
Long-term trade receivables, receivables in respect of capital
|
||||||||
leases and other receivables
|
1,101 | 2,204 | ||||||
Total long-term investments and receivables
|
14,928 | 17,012 | ||||||
PROPERTY AND EQUIPMENT, NET
|
99,201 | 100,532 | ||||||
INTANGIBLE ASSETS AND DEFERRED CHARGES, NET
|
2,651 | 2,988 | ||||||
TOTAL ASSETS
|
358,437 | 357,228 |
GILAT SATELLITE NETWORKS LTD.
|
CONDENSED CONSOLIDATED BALANCE SHEET
|
US dollars in thousands
|
June 30,
|
December 31,
|
|||||||
2010
|
2009
|
|||||||
Unaudited
|
||||||||
LIABILITIES AND EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Current maturities of long-term loans and convertible notes
|
5,174 | 5,220 | ||||||
Trade payables
|
16,918 | 16,838 | ||||||
Accrued expenses
|
19,742 | 20,067 | ||||||
Short-term advances from customer, held by trustees
|
6,669 | 2,137 | ||||||
Other current liabilities
|
28,576 | 28,154 | ||||||
Total current liabilities
|
77,079 | 72,416 | ||||||
LONG-TERM LIABILITIES:
|
||||||||
Accrued severance pay
|
9,775 | 10,011 | ||||||
Long-term loans, net
|
8,795 | 9,830 | ||||||
Accrued interest related to restructured debt
|
871 | 1,176 | ||||||
Convertible subordinated notes
|
14,799 | 15,220 | ||||||
Other long-term liabilities
|
15,387 | 16,280 | ||||||
Total long-term liabilities
|
49,627 | 52,517 | ||||||
COMMITMENTS AND CONTINGENCIES
|
||||||||
EQUITY:
|
||||||||
Share capital - ordinary shares of NIS 0.2 par value
|
1,842 | 1,832 | ||||||
Additional paid in capital
|
864,072 | 863,337 | ||||||
Accumulated other comprehensive income
|
723 | 1,341 | ||||||
Accumulated deficit
|
(634,906 | ) | (634,215 | ) | ||||
Total equity
|
231,731 | 232,295 | ||||||
TOTAL LIABILITIES AND EQUITY
|
358,437 | 357,228 |
Six months ended | Three months ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
|||||||||||||
Revenues
|
108,903 | 116,829 | 51,791 | 56,003 | ||||||||||||
Cost of revenues
|
72,413 | 81,851 | 34,938 | 38,979 | ||||||||||||
Gross profit
|
36,490 | 34,978 | 16,853 | 17,024 | ||||||||||||
Research and development expenses:
|
||||||||||||||||
Expenses incurred
|
9,472 | 8,095 | 4,749 | 4,086 | ||||||||||||
Less - grants
|
1,485 | 1,185 | 1,270 | 950 | ||||||||||||
7,987 | 6,910 | 3,479 | 3,136 | |||||||||||||
Selling, marketing, general and administrative expenses
|
29,856 | 28,510 | 14,783 | 14,380 | ||||||||||||
Operating loss
|
(1,353 | ) | (442 | ) | (1,409 | ) | (492 | ) | ||||||||
Financial income (expenses), net
|
10 | (227 | ) | (59 | ) | (568 | ) | |||||||||
Other income
|
- | 199 | - | - | ||||||||||||
Loss before taxes on income
|
(1,343 | ) | (470 | ) | (1,468 | ) | (1,060 | ) | ||||||||
Taxes on income (tax benefit)
|
(652 | ) | 495 | (135 | ) | 143 | ||||||||||
Net loss
|
(691 | ) | (965 | ) | (1,333 | ) | (1,203 | ) | ||||||||
Basic net loss per share
|
(0.02 | ) | (0.02 | ) | (0.03 | ) | (0.03 | ) | ||||||||
Diluted net loss per share
|
(0.02 | ) | (0.02 | ) | (0.03 | ) | (0.03 | ) | ||||||||
Weighted average number of shares used in
|
||||||||||||||||
computing net loss per share
|
||||||||||||||||
Basic
|
40,356 | 40,102 | 40,403 | 40,133 | ||||||||||||
Diluted
|
40,356 | 40,102 | 40,403 | 40,133 |
Six months ended | Three months ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
|||||||||||||
GAAP operating loss
|
(1,353 | ) | (442 | ) | (1,409 | ) | (492 | ) | ||||||||
Non-cash stock-based compensation expenses (1)
|
734 | 449 | 402 | 221 | ||||||||||||
Non-GAAP operating income (loss)
|
(619 | ) | 7 | (1,007 | ) | (271 | ) | |||||||||
GAAP net loss
|
(691 | ) | (965 | ) | (1,333 | ) | (1,203 | ) | ||||||||
Non-cash stock-based compensation expenses (1)
|
734 | 449 | 402 | 221 | ||||||||||||
Non-GAAP net income (loss)
|
43 | (516 | ) | (931 | ) | (982 | ) | |||||||||
GAAP Loss per share (diluted)
|
(0.02 | ) | (0.02 | ) | (0.03 | ) | (0.03 | ) | ||||||||
Non-cash stock-based compensation expenses (1)
|
0.02 | 0.01 | 0.01 | 0.01 | ||||||||||||
Non-GAAP Loss per share (diluted)
|
- | (0.01 | ) | (0.02 | ) | (0.02 | ) | |||||||||
Non-cash stock-based compensation expenses:
|
||||||||||||||||
Cost of Revenues
|
134 | 77 | 67 | 37 | ||||||||||||
Research and development
|
78 | 37 | 43 | 18 | ||||||||||||
Selling, general, marketing and administrative
|
522 | 335 | 292 | 166 | ||||||||||||
734 | 449 | 402 | 221 |
Six months ended | Three months ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
|||||||||||||
Cash flows from operating activities:
|
||||||||||||||||
Net loss
|
(691 | ) | (965 | ) | (1,333 | ) | (1,203 | ) | ||||||||
Adjustments required to reconcile net loss to net
cash provided by (used in) operating activities:
|
||||||||||||||||
Depreciation and amortization
|
6,218 | 7,259 | 3,205 | 3,804 | ||||||||||||
Gain from redemption of convertible notes
|
- | (22 | ) | - | (22 | ) | ||||||||||
Gain from the sale of an investment accounted for at cost
|
- | (199 | ) | - | - | |||||||||||
Stock-based compensation related to employees
|
734 | 449 | 402 | 221 | ||||||||||||
Accrued severance pay, net
|
241 | (494 | ) | 127 | (201 | ) | ||||||||||
Accrued interest and exchange rate differences on
|
||||||||||||||||
short and long-term restricted cash, net
|
19 | 155 | 168 | (108 | ) | |||||||||||
Accrued interest and exchange rate differences on
|
||||||||||||||||
marketable securities and short term bank deposits, net
|
110 | (277 | ) | 171 | (357 | ) | ||||||||||
Exchange rate differences on long-term loans
|
(915 | ) | 81 | (495 | ) | 366 | ||||||||||
Exchange rate differences on loans to employees
|
1 | - | 1 | (5 | ) | |||||||||||
Capital loss from disposal of property and equipment
|
245 | 64 | 238 | 59 | ||||||||||||
Deferred income taxes
|
6 | 215 | (5 | ) | 181 | |||||||||||
Decrease in trade receivables, net
|
1,602 | 8,835 | 10,384 | 7,317 | ||||||||||||
Decrease in other assets (including short-term, long-term
|
||||||||||||||||
and deferred charges)
|
(2,143 | ) | 7,082 | (2,356 | ) | (1,027 | ) | |||||||||
Decrease (increase) in inventories
|
(871 | ) | 6,152 | 1,036 | 4,876 | |||||||||||
Increase (decrease) in trade payables
|
92 | (13,663 | ) | 1,106 | (6,977 | ) | ||||||||||
Decrease in accrued expenses
|
(626 | ) | (3,359 | ) | (1,827 | ) | (1,652 | ) | ||||||||
Increase (decrease) in advances from customer, held
|
||||||||||||||||
by trustees, net
|
4,532 | (10,963 | ) | 5,813 | (8,065 | ) | ||||||||||
Increase (decrease) in other accounts payable and other long term liabilities
|
(274 | ) | (6,915 | ) | 1,303 | 1,802 | ||||||||||
Net cash provided by (used in) operating activities
|
8,280 | (6,565 | ) | 17,938 | (991 | ) |
Six months ended | Three months ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
|||||||||||||
Cash flows from investing activities:
|
||||||||||||||||
Purchase of property and equipment
|
(3,725 | ) | (1,873 | ) | (2,732 | ) | (1,081 | ) | ||||||||
Proceeds from sale of an investment accounted for at cost
|
- | 199 | - | - | ||||||||||||
Purchase of held-to-maturity marketable securities and deposits
|
(30,693 | ) | (74,077 | ) | - | (13,265 | ) | |||||||||
Proceeds from held-to-maturity marketable securities and deposits
|
39,877 | 73,212 | 31,924 | 13,929 | ||||||||||||
Purchase of available-for-sale marketable securities
|
(4,804 | ) | - | - | - | |||||||||||
Loans to employees, net
|
1 | 12 | 2 | 15 | ||||||||||||
Investment in restricted cash held by trustees
|
(11,110 | ) | - | (9,706 | ) | - | ||||||||||
Proceeds from restricted cash held by trustees
|
6,555 | 10,848 | 3,768 | 8,211 | ||||||||||||
Investment in restricted cash (including long-term)
|
(421 | ) | (87 | ) | (34 | ) | (37 | ) | ||||||||
Proceeds from restricted cash (including long-term)
|
1,332 | 998 | 1,262 | 801 | ||||||||||||
Net cash provided by (used in) investing activities
|
(2,988 | ) | 9,232 | 24,484 | 8,573 | |||||||||||
Cash flows from financing activities:
|
||||||||||||||||
Early redemption and repyament of convertible notes
|
(420 | ) | (45 | ) | (420 | ) | (45 | ) | ||||||||
Issuance of restricted stock units
|
10 | 6 | 5 | 3 | ||||||||||||
Repayment of long-term loans
|
(166 | ) | (167 | ) | (79 | ) | (86 | ) | ||||||||
Net cash used in financing activities
|
(576 | ) | (206 | ) | (494 | ) | (128 | ) | ||||||||
Effect of exchange rate changes on cash and cash equivalents
|
(79 | ) | 503 | (20 | ) | 488 | ||||||||||
Increase in cash and cash equivalents
|
4,637 | 2,964 | 41,908 | 7,942 | ||||||||||||
Cash and cash equivalents at the beginning of the period
|
122,672 | 73,916 | 85,401 | 68,938 | ||||||||||||
Cash and cash equivalents at the end of the period
|
127,309 | 76,880 | 127,309 | 76,880 |
Six months ended | Three months ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2010
|
2009
|
2010
|
2009
|
|||||||||||||
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
|||||||||||||
Operating loss
|
(1,353 | ) | (442 | ) | (1,409 | ) | (492 | ) | ||||||||
Add:
|
||||||||||||||||
Non-cash stock-based compensation expenses
|
734 | 449 | 402 | 221 | ||||||||||||
Deprecation and amortization
|
6,218 | 7,259 | 3,205 | 3,804 | ||||||||||||
EBITDA
|
5,599 | 7,266 | 2,198 | 3,533 |